| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
5.092 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
ACE |
ACE, DCP, DCP1: Angiotensin-converting enzyme, testis-specific isoform precursor |
5.092 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
DSPG3 |
EPYC, DSPG3, PGLB: Epiphycan precursor |
5.092 |
Evidence |
|
| PDGFA |
PDGFA, PDGF1: Platelet-derived growth factor A chain precursor |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
5.092 |
Evidence |
|
| IKBKB |
IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
5.092 |
Evidence |
|
| HIST3H3 |
HIST3H3, H3FT: Histone H3.1t |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
5.09 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
TAGLN |
TAGLN, SM22, WS3-10: Transgelin |
5.09 |
Evidence |
|
| TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
HIST3H3 |
HIST3H3, H3FT: Histone H3.1t |
5.09 |
Evidence |
O
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST3H3 |
HIST3H3, H3FT: Histone H3.1t |
5.09 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
5.09 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
5.09 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
ULBP2 |
ULBP2, N2DL2, UNQ463/PRO791, RAET1H: NKG2D ligand 2 precursor |
5.087 |
Evidence |
|
| RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
5.085 |
Evidence |
O
|
| NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
ANKS1A |
ANKS1A, ANKS1, KIAA0229: Ankyrin repeat and SAM domain-containing protein 1A |
5.08 |
Evidence |
|
| SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
5.08 |
Evidence |
|
| ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
CSTF2T |
CSTF2T, KIAA0689: Cleavage stimulation factor 64 kDa subunit, tau variant |
5.08 |
Evidence |
|
| VSNL1 |
VSNL1, VISL1: Visinin-like protein 1 |
CNN2 |
CNN2: Calponin-2 |
5.08 |
Evidence |
|
| LSM3 |
LSM3, MDS017: U6 snRNA-associated Sm-like protein LSm3 |
WDR54 |
IPI00029811 |
5.08 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CNN2 |
CNN2: Calponin-2 |
5.08 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
5.08 |
Evidence |
|
| COL3A1 |
COL3A1: Collagen alpha-1(III) chain precursor |
C1QTNF4 |
C1QTNF4, CTRP4: Complement C1q tumor necrosis factor-related protein 4 precursor |
5.08 |
Evidence |
|
| F12 |
F12: Coagulation factor XII precursor |
SPINK2 |
SPINK2: Serine protease inhibitor Kazal-type 2 precursor |
5.08 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
5.08 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
CHUK |
IPI00556043 |
5.08 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
GRLF1 |
IPI00477498 |
5.08 |
Evidence |
|
- 
-